October 14, 2014 A Phase I clinical trial of an Ebola vaccine developed in Canada just began at the Walter Reed Army Institute of Research in the U.S. Another Phase I trial of an Ebola vaccine developed by the NIH’s National Institute of Allergy and Infectious Diseases has been launched ...
Somsri WiwanitkitViroj WiwanitkitAsian Pacific Journal of Tropical BiomedicineWiwanitkit S, Wiwanitkit V. Ebola vaccine 2014: remained problems to be answered. Asian Pac J Trop Biomed 2015; 5(2): 85-86.
In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebolavirus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past. The vaccine was one of two being exa...
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and th
How do you test an Ebola vaccine? Scientists in West Africa are racing to determine what immunization strategies could be most effective to contain the epidemic. Ewen Callaway News Explainer18 Dec 2014 Nature First trials of blood-based Ebola therapy kick off Trials of 'convalescent' plasma...
It is expecting to consider the emergency use of Ebola vaccines by the end of 2014.【1】What does the article mainly talk about?A.How vaccinations protect us from dangerous diseases.B.The common efforts of scientists to find a cure for Ebola.C.How the first vaccine and vaccinations came ...
Mariannesaid this onSeptember 28, 2014 at 12:14 pm|Reply The Govn want the ebola to spread but even if it does not the PERCEPTION that it has spread is the key to enforce the vaccine. To most healthy people ebola is not a threat – the disease is nothing , the terrain is everythin...
Johnson & Johnsonhad already begun working on a potential vaccine for filoviruses—a family of viruses that includesEbola. In the wake of the 2014 outbreak, the company accelerated those efforts with a focus on Ebola, and continued that work even when the crisis in West Africa had passed. ...
The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the 2014 West Africa outbreak and is behind more than 2200 deaths in the current outbreak in the...
We had to set up a full laboratory in a week, to process thousands of samples. Delivering the vaccine requiredultra cold freezers (minus 80°C); none were available in the country. We had to addressvaccine hesitancyamong the population of Guinea, including the medical and academic community. ...